METTL14-mediated m6A modification enhances USP22-ERα axis to drive breast cancer malignancy.
Zhuang X, Yin S, Cheng J, Sun W, Fang Z, Xiang Y, Peng EY, Yao Y, Li Y, He X, Lu L, Deng Y, Huang H, Cai G, Liao Y.
Zhuang X, et al. Among authors: cheng j.
Pharmacol Res. 2024 Nov 16:107509. doi: 10.1016/j.phrs.2024.107509. Online ahead of print.
Pharmacol Res. 2024.
PMID: 39557350